90 related articles for article (PubMed ID: 28385536)
21. Initiation and adaptation: a paradigm for understanding psychotropic drug action.
Hyman SE; Nestler EJ
Am J Psychiatry; 1996 Feb; 153(2):151-62. PubMed ID: 8561194
[TBL] [Abstract][Full Text] [Related]
22. Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression.
Corena-McLeod Mdel P; Oliveros A; Charlesworth C; Madden B; Liang YQ; Boules M; Shaw A; Williams K; Richelson E
Brain Res; 2008 Oct; 1233():8-19. PubMed ID: 18657526
[TBL] [Abstract][Full Text] [Related]
23. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation.
Yu IT; Park JY; Kim SH; Lee JS; Kim YS; Son H
Neuropharmacology; 2009 Feb; 56(2):473-80. PubMed ID: 19007798
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study of the normothymic effect of dipropylacetamide].
Semadeni GW
Acta Psychiatr Belg; 1976 May; 76(3):458-66. PubMed ID: 798467
[TBL] [Abstract][Full Text] [Related]
25. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
Gould TD; Manji HK
Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
[TBL] [Abstract][Full Text] [Related]
26. Using Literature-Based Discovery to Explain Adverse Drug Effects.
Hristovski D; Kastrin A; Dinevski D; Burgun A; Žiberna L; Rindflesch TC
J Med Syst; 2016 Aug; 40(8):185. PubMed ID: 27318993
[TBL] [Abstract][Full Text] [Related]
27. Computational Approaches for Mining GRO-Seq Data to Identify and Characterize Active Enhancers.
Nagari A; Murakami S; Malladi VS; Kraus WL
Methods Mol Biol; 2017; 1468():121-38. PubMed ID: 27662874
[TBL] [Abstract][Full Text] [Related]
28. Quantitative inference of dynamic regulatory pathways via microarray data.
Chang WC; Li CW; Chen BS
BMC Bioinformatics; 2005 Mar; 6():44. PubMed ID: 15748298
[TBL] [Abstract][Full Text] [Related]
29. How can the mood stabilizer VPA limit both mania and depression?
Cheng L; Lumb M; Polgár L; Mudge AW
Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340
[TBL] [Abstract][Full Text] [Related]
30. [New developments in preventive therapy of manic-depressive disease].
Schou M
Psychiatr Neurol Med Psychol Beih; 1988; 41():60-3. PubMed ID: 3151400
[No Abstract] [Full Text] [Related]
31. Genome-wide prediction of transcriptional regulatory elements of human promoters using gene expression and promoter analysis data.
Kim SY; Kim Y
BMC Bioinformatics; 2006 Jul; 7():330. PubMed ID: 16817975
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of GluK2 kainate receptor expression by chronic treatment with mood-stabilizing anti-convulsants or lithium in cultured astrocytes and brain, but not in neurons.
Li B; Zhang S; Li M; Zhang H; Hertz L; Peng L
Neuropharmacology; 2009 Sep; 57(4):375-85. PubMed ID: 19596362
[TBL] [Abstract][Full Text] [Related]
33. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
34. Chromosome conformation elucidates regulatory relationships in developing human brain.
Won H; de la Torre-Ubieta L; Stein JL; Parikshak NN; Huang J; Opland CK; Gandal MJ; Sutton GJ; Hormozdiari F; Lu D; Lee C; Eskin E; Voineagu I; Ernst J; Geschwind DH
Nature; 2016 Oct; 538(7626):523-527. PubMed ID: 27760116
[TBL] [Abstract][Full Text] [Related]
35. Continued colonization of the human genome by mitochondrial DNA.
Ricchetti M; Tekaia F; Dujon B
PLoS Biol; 2004 Sep; 2(9):E273. PubMed ID: 15361937
[TBL] [Abstract][Full Text] [Related]
36. Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database.
Kim S; Zavitsanou K; Gurguis G; Webster MJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):683-94. PubMed ID: 22356822
[TBL] [Abstract][Full Text] [Related]
37. Specificity of mood stabilizer action on neuronal growth cones.
Shaltiel G; Dalton EC; Belmaker RH; Harwood AJ; Agam G
Bipolar Disord; 2007 May; 9(3):281-9. PubMed ID: 17430303
[TBL] [Abstract][Full Text] [Related]
38. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
Di Daniel E; Mudge AW; Maycox PR
Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
[TBL] [Abstract][Full Text] [Related]
40. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
